Financial Architects (New Jersey)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,000
Closed -$304K 911
2019
Q3
$304K Buy
6,000
+4,000
+200% +$188K 0.07% 186
2019
Q2
$91K Hold
2,000
0.02% 398
2019
Q1
$95K Buy
+2,000
New +$99.6K 0.02% 463

Other funds holding BMY

Financial Architects (New Jersey)'s BMY Position: Q2 2023 in Review

Financial Architects (New Jersey) reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2023, selling an estimated $57.5K and leaving 7,122 shares worth $455K. The position accounts for 0.07% of the portfolio, ranked #217.

Financial Architects (New Jersey) first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.18M in Q4 2016. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Financial Architects (New Jersey) held 7,122 shares of Bristol-Myers Squibb worth $455K as of Q2 2023.
  • Financial Architects (New Jersey) sold 857 Bristol-Myers Squibb shares in Q2 2023, an estimated $57.5K.
  • Bristol-Myers Squibb made up 0.07% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #217 holding.
  • Financial Architects (New Jersey) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
  • Financial Architects (New Jersey)'s Bristol-Myers Squibb position peaked at $1.18M in Q4 2016.
  • 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.